Tanzania - English - Tanzania Medicinces & Medical Devices Authority

hetero laboratories limited, india - nirmatrelvir & ritonavir - tablets - nirmatrelvir - 150 mg & ritonavir - 100mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - nirmatrelvir; ritonavir -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pfizer (malaysia) sdn. bhd. - nirmatrelvir; ritonavir -

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - ofirmev® (acetaminophen) injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older the management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older the reduction of fever in adult and pediatric patients. acetaminophen is contraindicated: in patients with known hypersensitivity to acetaminophen or to any of the excipients in the intravenous formulation. in patients with severe hepatic impairment or severe active liver disease [see warnings and precautions (5.1)]. risk summary published epidemiological studies with oral acetaminophen use during pregnancy have not reported a clear association with acetaminophen use and birth defects, miscarriage, or adverse maternal or fetal outcomes [see data]. animal reproduction studies have not been conducted with iv acetaminophen. reproductive and developmental studies in rats and mice from the published literature identified adverse even

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

pfizer ltd - nirmatrelvir - oral tablet - 150mg

United States - English - NLM (National Library of Medicine)

mallinckrodt hospital products inc. - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d) - acetaminophen 10 mg in 1 ml - ofirmev® (acetaminophen) injection is indicated for - the management of mild to moderate pain in adult and pediatric patients 2 years and older - the management of moderate to severe pain with adjunctive opioid analgesics in adult and pediatric patients 2 years and older - the reduction of fever in adult and pediatric patients. acetaminophen is contraindicated: - in patients with known hypersensitivity to acetaminophen or to any of the excipients in the intravenous formulation. - in patients with severe hepatic impairment or severe active liver disease [see warnings and precautions (5.1)] . risk summary published epidemiological studies with oral acetaminophen use during pregnancy have not reported a clear association with acetaminophen use and birth defects, miscarriage, or adverse maternal or fetal outcomes [see data] . animal reproduction studies have not been conducted with iv acetaminophen. reproductive and developmental studies in rats and mice from the published literature identified adverse events at

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

pfizer pharmaceuticals inc. - nirmatrelvir; ritonavir - nirmatrelvir: pale red tablet, major axis; 17.5 mm, minor axis; 8.5 mm, thickness; 5.7 mm/ritonavir: white to faintly yellowish white tablet, major axis; approx. 17 mm, minor axis; approx. 9 mm, thickness; approx. 6 mm

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate ; sodium gluconate - solution for infusion - 148 (ph 7.4) - solutions affecting the electrolyte balance; electrolytes

United States - English - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - nirmatrelvir (unii: 7r9a5p7h32) (nirmatrelvir - unii:7r9a5p7h32) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) for the emergency use of paxlovid for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) with mild-to-moderate coronavirus disease 2019 (covid-19) and who are at high risk1 for progression to severe covid-19, including hospitalization or death. limitations of authorized use paxlovid is not authorized for use as pre-exposure or post-exposure prophylaxis for prevention of covid-19 [see clinical studies (14.3)] . paxlovid may be prescribed for an individual patient by physicians, advanced practice registered nurses, and physician assistants that are licensed or authorized under state law to prescribe drugs. paxlovid may also be prescribed for an individual patient by a state-licensed pharmacist under the following conditions: the state-licensed pharmacist should refer an individual patient for clinical evaluation (e.g., telehealth, in-person visit) with a physician, advanced